Correlation Between Reviva Pharmaceuticals and ProQR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and ProQR Therapeutics BV, you can compare the effects of market volatilities on Reviva Pharmaceuticals and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and ProQR Therapeutics.
Diversification Opportunities for Reviva Pharmaceuticals and ProQR Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Reviva and ProQR is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and ProQR Therapeutics go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and ProQR Therapeutics
Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to generate 1.85 times more return on investment than ProQR Therapeutics. However, Reviva Pharmaceuticals is 1.85 times more volatile than ProQR Therapeutics BV. It trades about 0.09 of its potential returns per unit of risk. ProQR Therapeutics BV is currently generating about -0.09 per unit of risk. If you would invest 114.00 in Reviva Pharmaceuticals Holdings on November 27, 2024 and sell it today you would earn a total of 32.00 from holding Reviva Pharmaceuticals Holdings or generate 28.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. ProQR Therapeutics BV
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| ProQR Therapeutics |
Reviva Pharmaceuticals and ProQR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and ProQR Therapeutics
The main advantage of trading using opposite Reviva Pharmaceuticals and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
| ProQR Therapeutics vs. Annexon | ProQR Therapeutics vs. Arrowhead Pharmaceuticals | ProQR Therapeutics vs. Day One Biopharmaceuticals | ProQR Therapeutics vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |